CapWealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $32.8M | Sell |
235,217
-9,394
| -4% | -$1.32M | 2.43% | 9 |
|
|
2025
Q4 | $30M | Buy |
244,611
+1,004
| +0.4% | +$122K | 2.05% | 15 |
|
|
2025
Q3 | $27M | Sell |
243,607
-9,320
| -4% | -$1.06M | 1.86% | 21 |
|
|
2025
Q2 | $28M | Sell |
252,927
-1,317
| -0.5% | -$140K | 2.76% | 7 |
|
|
2025
Q1 | $28.5M | Buy |
254,244
+529
| +0.2% | +$54.6K | 3.08% | 9 |
|
|
2024
Q4 | $23.4M | Sell |
253,715
-4,276
| -2% | -$385K | 2.57% | 12 |
|
|
2024
Q3 | $21.6M | Buy |
257,991
+349
| +0.1% | +$26.6K | 2.35% | 13 |
|
|
2024
Q2 | $17.7M | Sell |
257,642
-10,396
| -4% | -$694K | 2.23% | 19 |
|
|
2024
Q1 | $19.6M | Buy |
268,038
+4,947
| +2% | +$380K | 2.2% | 18 |
|
|
2023
Q4 | $21.3M | Sell |
263,091
-7,374
| -3% | -$574K | 2.6% | 15 |
|
|
2023
Q3 | $20.3M | Sell |
270,465
-5,363
| -2% | -$413K | 2.6% | 13 |
|
|
2023
Q2 | $21.3M | Sell |
275,828
-3,852
| -1% | -$307K | 2.59% | 14 |
|
|
2023
Q1 | $23.2M | Sell |
279,680
-4,255
| -1% | -$352K | 2.89% | 8 |
|
|
2022
Q4 | $24.4M | Sell |
283,935
-841
| -0.3% | -$66.6K | 2.86% | 10 |
|
|
2022
Q3 | $17.6M | Buy |
284,776
+3,784
| +1% | +$239K | 2.32% | 15 |
|
|
2022
Q2 | $17.4M | Buy |
280,992
+9,294
| +3% | +$575K | 2.09% | 19 |
|
|
2022
Q1 | $16.2M | Sell |
271,698
-3,852
| -1% | -$246K | 1.65% | 21 |
|
|
2021
Q4 | $20M | Buy |
275,550
+2,786
| +1% | +$192K | 2.04% | 16 |
|
|
2021
Q3 | $19.1M | Buy |
272,764
+619
| +0.2% | +$43.5K | 2.09% | 16 |
|
|
2021
Q2 | $18.7M | Buy |
272,145
+38,969
| +17% | +$2.6M | 2.03% | 18 |
|
|
2021
Q1 | $15.1M | Buy |
233,176
+21,161
| +10% | +$1.36M | 1.71% | 25 |
|
|
2020
Q4 | $12.4M | Buy |
212,015
+60,938
| +40% | +$3.68M | 1.47% | 32 |
|
|
2020
Q3 | $9.55M | Buy |
151,077
+2,233
| +2% | +$155K | 1.28% | 33 |
|
|
2020
Q2 | $11.5M | Buy |
148,844
+11,608
| +8% | +$890K | 1.62% | 26 |
|
|
2020
Q1 | $10.3M | Buy |
+137,236
| New | +$9.48M | 1.81% | 21 |
|
|
2019
Q3 | – | Sell |
-11,359
| Closed | -$767K | – | 100 |
|
|
2019
Q2 | $767K | Sell |
11,359
-70,811
| -86% | -$4.66M | 0.11% | 63 |
|
|
2019
Q1 | $5.34M | Sell |
82,170
-9,073
| -10% | -$603K | 0.82% | 41 |
|
|
2018
Q4 | $5.71M | Sell |
91,243
-36,321
| -28% | -$2.54M | 1% | 37 |
|
|
2018
Q3 | $9.85M | Buy |
127,564
+1,521
| +1% | +$115K | 1.62% | 24 |
|
|
2018
Q2 | $8.93M | Sell |
126,043
-20,423
| -14% | -$1.44M | 1.6% | 23 |
|
|
2018
Q1 | $11M | Sell |
146,466
-4,746
| -3% | -$377K | 2.14% | 18 |
|
|
2017
Q4 | $10.8M | Buy |
151,212
+1,721
| +1% | +$131K | 1.95% | 20 |
|
|
2017
Q3 | $12.1M | Buy |
149,491
+29
| +0% | +$2.22K | 2.33% | 15 |
|
|
2017
Q2 | $10.6M | Buy |
149,462
+3,543
| +2% | +$236K | 2.12% | 18 |
|
|
2017
Q1 | $9.91M | Buy |
145,919
+8,189
| +6% | +$576K | 2.03% | 19 |
|
|
2016
Q4 | $9.86M | Sell |
137,730
-10,089
| -7% | -$750K | 2.13% | 17 |
|
|
2016
Q3 | $11.7M | Buy |
147,819
+34,718
| +31% | +$2.82M | 2.81% | 11 |
|
|
2016
Q2 | $9.44M | Buy |
113,101
+3,066
| +3% | +$272K | 2.31% | 15 |
|
|
2016
Q1 | $10.1M | Buy |
110,035
+2,526
| +2% | +$228K | 2.57% | 12 |
|
|
2015
Q4 | $10.9M | Sell |
107,509
-535
| -0.5% | -$55.7K | 2.63% | 13 |
|
|
2015
Q3 | $10.6M | Buy |
108,044
+7,671
| +8% | +$852K | 2.66% | 10 |
|
|
2015
Q2 | $11.8M | Buy |
100,373
+3,810
| +4% | +$416K | 2.77% | 12 |
|
|
2015
Q1 | $9.48M | Buy |
96,563
+4,400
| +5% | +$447K | 2.23% | 15 |
|
|
2014
Q4 | $8.69M | Sell |
92,163
-8,527
| -8% | -$882K | 2.04% | 18 |
|
|
2014
Q3 | $10.7M | Buy |
100,690
+4,982
| +5% | +$488K | 2.43% | 12 |
|
|
2014
Q2 | $7.93M | Buy |
95,708
+11,730
| +14% | +$913K | 1.82% | 17 |
|
|
2014
Q1 | $5.95M | Buy |
83,978
+11,668
| +16% | +$915K | 1.6% | 29 |
|
|
2013
Q4 | $5.43M | Buy |
72,310
+22,110
| +44% | +$1.54M | 1.37% | 30 |
|
|
2013
Q3 | $3.16M | Buy |
50,200
+7,275
| +17% | +$435K | 0.88% | 44 |
|
|
2013
Q2 | $2.2M | Buy |
+42,925
| New | +$2.24M | 0.64% | 46 |
|
Other funds holding GILD
VCM
VPM
CapWealth Advisors's GILD Position: Q1 2026 in Review
CapWealth Advisors reduced its Gilead Sciences (GILD) stake by 3.8% in Q1 2026, selling an estimated $1.32M and leaving 235,217 shares worth $32.8M. The position accounts for 2.43% of the portfolio, ranked #9.
CapWealth Advisors first reported a position in GILD in Q2 2013 and has held it in 50 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- CapWealth Advisors held 235,217 shares of Gilead Sciences worth $32.8M as of Q1 2026.
- CapWealth Advisors sold 9,394 Gilead Sciences shares in Q1 2026, an estimated $1.32M.
- Gilead Sciences made up 2.43% of CapWealth Advisors's portfolio in Q1 2026, its #9 holding.
- CapWealth Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 50 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on CapWealth Advisors's 13F filing for Q1 2026, filed 5 May 2026.